Prescriptions Blog: Orexigen and F.D.A. Revive Study of Contrave, a Diet Pill

Wednesday, September 21, 2011 - 10:40 in Mathematics & Economics

The Food and Drug Administration and Orexigen reached agreement on new trial standards for Contrave, a pill the agency had rejected earlier this year.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net